Is there another benefit besides weight loss of GLP-1s in people with severe obesity? Elizabeth Tracey reports

from Johns Hopkins Medicine · host Johns Hopkins Medicine

GLP-1 receptor agonists are effective in helping most people lose weight, and now a new study suggests that in those with severe obesity, a BMI of 42 or greater and who have a type of heart failure, this condition may … Is there another benefit besides weight loss of GLP-1s in people with severe obesity? Elizabeth Tracey reports Read More »

Episode metadata supplied by the publisher feed · Published Apr 23, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Is there another benefit besides weight loss of GLP-1s in people with severe obesity? Elizabeth Tracey reports

0:00 1:04

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Johns Hopkins Medicine?

This episode is 1 minute long.

When was this Johns Hopkins Medicine episode published?

This episode was published on April 23, 2026.

Can I download this Johns Hopkins Medicine episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!